Organization
Shandong University
21 clinical trials
1 abstract
Abstract
Distribution and mutational landscape of inherited cancer susceptibility syndromes in central nervous system tumors.Org: Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd.,
Clinical trial
Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations With High Risk for EOSStatus: Recruiting, Estimated PCD: 2026-07-01
Clinical trial
Evaluation of Efficacy of AHCC®for the Clearance of High Risk-HPV Infections in Chinese Female: A Multi-centre, Randomised, Double Blind and Placebo-controlled StudyStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Effect of Metformin on Healthy Live Birth After In-vitro Fertilization in Women With Prediabetes Mellitus: a Multicenter Double-blind Placebo Controlled Randomized TrialStatus: Recruiting, Estimated PCD: 2026-12-31
Clinical trial
The Efficacy and Safety of Secondary Prophylaxis Versus ANC< 1000/mm3 Administration of PEG-rhG-CSF in Patients Receiving Cytotoxic Chemotherapy for Gynecologic MalignanciesStatus: Terminated, Estimated PCD: 2020-12-31
Clinical trial
High-dose Dexamethasone Plus Hetrombopag Versus High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia (ITP):A Prospective Multicenter Randomized TrialStatus: Recruiting, Estimated PCD: 2024-07-10
Clinical trial
Model-based Dose Versus Empirical Dose of Piperacillin/Tazobactam in the Treatment of Late-onset Sepsis in Preterm Neonates: a Multicentre, Randomised, Open-label, Non-inferiority Study.Status: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Triple Versus Quadruple Therapy With Amoxicillin and Tetracycline for the Eradication of Helicobacter Pylori: A Multicenter Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2024-10-01
Clinical trial
Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer Based on High-Resolution Dynamic Immune Signature AnalysisStatus: Not yet recruiting, Estimated PCD: 2026-02-28
Clinical trial
Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma: A Multi-center, Open-label, Prospective Clinical StudyStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Multicenter Randomized Clinical Trial of 10 and 14 DaysStatus: Completed, Estimated PCD: 2023-05-30
Clinical trial
A Prospective, Open, Multicenter Clinical Trial of Eltrombopag Combined With Diacerein in the Management of Eltrombopag-inefficient or Relapsed ITPStatus: Completed, Estimated PCD: 2020-06-01
Clinical trial
A Study of Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen With Risk Factors:A Single-Arm, Multicenter Clinical TrialStatus: Recruiting, Estimated PCD: 2026-06-01
Clinical trial
Population Pharmacokinetics and Dose Optimization of Caspofungin in Adolescents With Allogeneic Hematopoietic Stem Cell TransplantationStatus: Completed, Estimated PCD: 2019-03-03
Clinical trial
14-day High-dose Tegoprazan Double Therapy Versus Bismuth Quadruple Therapy in First-line Treatment of Helicobacter Pylori Infection: a Prospective, Randomized, Controlled StudyStatus: Not yet recruiting, Estimated PCD: 2023-12-20
Clinical trial
Evaluate Efficacy and Safety of Serplulimab（HLX10）in Patients With Advanced, Recurrent and Metastatic Cervical Cancer：A Prospective, Multicenter, Non-interventive Real-world StudyStatus: Recruiting, Estimated PCD: 2024-03-31
Clinical trial
The Efficacy of Bismuth-containing Quadruple Therapy in the First-line Treatment of Helicobacter Pylori Infection in 10 Days and 14 Days: a Prospective, Randomized, Controlled StudyStatus: Not yet recruiting, Estimated PCD: 2023-10-31
Clinical trial
Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy: A Multicenter Randomized Non-Inferiority Trial of Different Tetracycline Doses and Frequencies.Status: Recruiting, Estimated PCD: 2023-08-01
Clinical trial
Efficacy and Safety of Abraxane With Bevacizumab Biosimilar in Patients With Recurrent, Platinum-resistant Epithelial Ovarian Cancer：A Multi-center, Prospective, One-arm, Phase II StudyStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
The Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication FailureStatus: Completed, Estimated PCD: 2023-02-10
Clinical trial
Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment: A Multicenter Randomized Clinical Trial of Different Tetracycline Doses and Frequencies.Status: Completed, Estimated PCD: 2024-02-01
Clinical trial
A Multicenter Randomized Controlled Study on the Treatment of Refractory CTIT With Romiplostim N01 Compared to Recombinant Human ThrombopoietinStatus: Not yet recruiting, Estimated PCD: 2025-06-01